ARCHIVES

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

This article is from The Cancer Letter archive.

Vol. 28 No. 38 | October 18, 2002

Download PDF Visit The Full Archive

Related Articles

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011

NIH to ban consulting by top officials, limit outside work by other employees.

June 25, 2004

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

September 25, 1998

Public Health Service: Blumenthal Transferred to Surgeon General’s office, HHS Says

November 7, 1997

NCI Agrees To give NSABP One Year Until Competition; Advisors OK Concept

June 17, 1994

ACS Courage award Goes To Polhill, Former Beirut Hostage

March 29, 1991